Navigation Links
MAP Pharmaceuticals to Present at Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., April 25 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the company will present at the following upcoming investor conferences on April 30th and May 6th, 2008:

Morgan Stanley Global Healthcare Conference, Key Biscayne, FL

Wednesday, April 30, 2008

9:10 am, Eastern Time

Deutsche Bank 33rd Annual Health Care Conference, Boston, MA

Tuesday, May 6, 2008

10:10 am, Eastern Time

A live webcast of the presentations will be available on the Investor Relations section of MAP Pharmaceuticals' website at A replay will also be available within 24 hours for seven days following the presentation.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals develops and plans to commercialize new therapies for children and adults who suffer from chronic conditions that it believes are not adequately treated by currently available medicines. The company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical development for the treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
2. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
3. Onyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
4. Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
5. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
6. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
7. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
8. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
11. Access Pharmaceuticals Announces New Data on Angiolix(R)
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... With Thanksgiving right ... is sharing safety tips to help protect your family and vehicle. , According to ... the 2013 Thanksgiving holiday weekend. Amica is sharing the following safety tips from the ...
(Date:11/24/2015)... Abington, PA (PRWEB) , ... November 24, 2015 ... ... announce that it has been designated an Aetna Institute of Quality® Bariatric Surgery ... information about the quality and cost of health care services available to its ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... award for its exceptional customer service: the TrustDale certification. The award recognizes good ... Baltimore stone honing , tile and grout, and hard surface restoration company ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Autism Speaks, ... the global movement driven by social media and the generosity of people around the ... encourage their social media networks to give – and share the personal stories behind ...
(Date:11/24/2015)... ... ... her life, Don Peck’s mother wondered if she was a descendant of Samuel Fuller, a ... a 25-year search for information, Don and his aunt discovered that she was not, in ... out, it was Don’s father who was descended from not one, but four passengers on ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  In the pharmaceutical ... in an effort to quickly uncover new insights, tactics ... --> --> However, organizations ... market research project and ensure that all rules and ... industry standards. Another major barrier to efficiently launching market ...
(Date:11/24/2015)... , Nov. 24, 2015  DILON Diagnostics and GE ... an agreement for DILON to distribute GE,s Discovery NM750b ... globe. The signing of this distribution agreement will provide Dilon,s ... Breast Imaging system and is considered an initial step ... healthcare solutions for clinicians and their patients. ...
(Date:11/24/2015)... 2015   HeartWare International, Inc . (NASDAQ: ... support technologies that are revolutionizing the treatment of advanced ... Officer Doug Godshall is scheduled to present ... Conference on December 1, 2015 at 3:00 p.m. ET.  ... New York . ...
Breaking Medicine Technology: